Jasvinder Singh, MD, MPH

University of Alabama at Birmingham
Birmingham, AL, United States

Dr. Singh is a Professor of medicine and epidemiology at the University of Alabama at Birmingham, Director of the Gout Clinic at the University of Alabama Health Sciences Foundation and a staff rheumatologist at the Birmingham Veterans Affairs Medical center. Dr. Singh’s research has focused on studies of outcomes in patients with rheumatic diseases, using databases and performing interventional studies to improve outcomes in patients with rheumatic diseases. His previous studies have focused on assessing correlates and predictors of patient-reported outcomes including quality of life, pain, and function in large cohorts of patients with gout, osteoarthritis and other types of musculoskeletal diseases. His current research interests include conducting translational and clinical research in patients with gout, osteoarthritis and lupus and studies assessing patient shared decision-making.

Disclosure information not submitted.

Presentation(s):

• In Advanced OA, Is Further Conservative Treatment Such as Bracing or Physical Therapy Effective Before THA/TKA or Just Introducing Delays to Surgery?

  Sunday, November 13, 2022
  3:15 PM – 3:30 PM Eastern Time

• 1821: Colchicine and Other Gout Medications and the Risk of COVID-19 Infection, Hospitalization, and Subsequent Outcomes in People with Gout

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• 14M152: Abstracts: RA – Treatment III: Comorbidities and Consequences (2215–2220)

  Monday, November 14, 2022
  3:00 PM – 4:30 PM Eastern Time